首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   471篇
  免费   9篇
  国内免费   7篇
耳鼻咽喉   7篇
儿科学   8篇
妇产科学   5篇
基础医学   132篇
口腔科学   15篇
临床医学   55篇
内科学   61篇
皮肤病学   3篇
神经病学   5篇
特种医学   32篇
外科学   63篇
综合类   4篇
预防医学   41篇
眼科学   4篇
药学   44篇
肿瘤学   8篇
  2022年   6篇
  2021年   5篇
  2018年   17篇
  2017年   4篇
  2015年   7篇
  2014年   10篇
  2013年   12篇
  2012年   10篇
  2011年   17篇
  2010年   11篇
  2009年   14篇
  2008年   11篇
  2007年   25篇
  2006年   14篇
  2005年   19篇
  2004年   13篇
  2003年   9篇
  2002年   15篇
  2001年   11篇
  2000年   8篇
  1999年   5篇
  1998年   10篇
  1997年   3篇
  1996年   3篇
  1995年   4篇
  1994年   3篇
  1993年   4篇
  1992年   8篇
  1991年   20篇
  1990年   16篇
  1989年   15篇
  1988年   12篇
  1987年   9篇
  1986年   13篇
  1985年   8篇
  1984年   9篇
  1983年   8篇
  1982年   4篇
  1979年   6篇
  1978年   10篇
  1977年   4篇
  1976年   6篇
  1974年   7篇
  1973年   7篇
  1972年   8篇
  1971年   5篇
  1970年   7篇
  1969年   8篇
  1966年   5篇
  1965年   3篇
排序方式: 共有487条查询结果,搜索用时 125 毫秒
1.
2.
In patients with benign and malignant brain tumors before the operation, the suppression of the immune system, in particular, proliferative response of lymphocytes to T- and B-mitogens was established. Preoperative preparation of the patients aggravated this process. At day 8-10 after the operation, normalization of the main indices of immunity in patients with benign tumors was noted. In malignant tumors after the operation, the increase in the contents of T- and B-lymphocytes against the background of decrease in their proliferative activity was observed.  相似文献   
3.
Research Institute of Physicochemical Medicine, Ministry of Health, Moscow. (Presented by Academician of the Academy of Medical Sciences Yu. M. Lopukhin.) Translated from Byulleten Éksperimental'noi Biologii i Meditsiny, Vol. 113, No. 5, pp. 488–489, May, 1992.  相似文献   
4.
In Russia for prevention of influenza in children, aged from 3 to 14 years, the children's live influenza vaccine (LIV), based upon A/Leningrad/134/47/57(H2N2) master strain (LIVI) is used. The need for double immunization appears to be one out of the faulties of this preparation. The study was aimed to comparing the safety, immunogenic activity and prevention of influenza by LIV for adults (LIVII) (A/Leningrad/134/17/57(H2N2 master strain) and LIVI in children aged from 7 to 17 years under similar administration schedule. The safety, the preventive efficacy, humoral and secretory immunity were studied. In total 2486 persons, including 539 children, twice inoculated with LIVI, 971 persons once inoculated with LIVII, and 840 treated by placebo were obserbed. From the data of the clinical observations during 7 days after immunization both vaccines appeared to be low reactogenic. The LIVII advantages in induction of the humoral and secretory antibodies in comparison with children's vaccine had been revealed. Both vaccines were highly efficacious, the efficiency of both preparations was more pronounced after serologic correction of the diagnosis. The results obtained permit to recommend the single immunization by the variant of LIV at the base on A/Leningrad/134/17/57/(H2N2) master strain for prevention of influenza in school children.  相似文献   
5.
BACKGROUND: The initial rate of plasma HIV-1 RNA (pVL) decline has been proposed as a marker of early efficacy of antiretroviral therapy (ART) and a possible predictor of late efficacy. We compared the rate of pVL decline in patients starting ART with nevirapine (NVP), efavirenz (EFV), or both drugs combined in addition to lamivudine (3TC) and stavudine (d4T). METHODS: Analysis of the viral decay constant (VDc) during the first 2 weeks of treatment in patients enrolled in the 2NN study who remained on allocated treatment. RESULTS: The median VDc (log10 copies per day, [interquartile range]) was similar for NVP (0.30 [0.25-0.36], EFV (0.31 [0.27-0.37]), and NVP + EFV (0.30 [0.27-0.36]). Patients with a baseline pVL >100,000 copies/mL were 8.7 (95% confidence interval [CI]: 6.2-12.3) times more likely to have a VDc >75th percentile. A high VDc was not associated with plasma drug concentration or with a decreased risk of virologic failure at week 48 after the start of therapy (hazard ratio = 0.8, 95% CI: 0.6-1.2). CONCLUSION: NVP, EFV, or NVP + EFV in combination with 3TC and d4T show similar rates of pVL decline during the first 2 weeks of treatment. The VDc with these regimens is not predictive of late virologic efficacy.  相似文献   
6.
7.
Trypanosoma brucei evades the immune system by switching between Variant Surface Glycoprotein (VSG) genes. The active VSG gene is transcribed in one of approximately 20 telomeric expression sites (ESs). It has been postulated that ES polymorphism plays a role in host adaptation. To gain more insight into ES architecture, we have determined the complete sequence of Bacterial Artificial Chromosomes (BACs) containing DNA from three ESs and their flanking regions. There was variation in the order and number of ES-associated genes (ESAGs). ESAGs 6 and 7, encoding transferrin receptor subunits, are the only ESAGs with functional copies in every ES that has been sequenced until now. A BAC clone containing the VO2 ES sequences comprised approximately half of a 330 kb 'intermediate' chromosome. The extensive similarity between this intermediate chromosome and the left telomere of T. brucei 927 chromosome I, suggests that this previously uncharacterised intermediate size class of chromosomes could have arisen from breakage of megabase chromosomes. Unexpected conservation of sequences, including pseudogenes, indicates that the multiple ESs could have arisen through a relatively recent amplification of a single ES.  相似文献   
8.
9.
The experience of the peritoneal dialysis (PD) successful application in 16 children of an early age was summarized. In all the patients the terminal state with an acute cardiac and renal insufficiency was noted after cardiosurgical operation conduction using artificial blood circulation. The improvement of hemodynamical indices, renal and pulmonary function as well, were promoted by an early application of PD.  相似文献   
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号